RankingsPricing
  1. JP-listed companies
  2. Takeda Pharmaceutical Company Limited
  3. Financials
  4. Diluted EPS

Takeda Pharmaceutical Company Limited【JP:4502】

Market cap
¥8.08T
P/E ratio
52.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 202567.2-26.25%
Mar 31, 202491.2-54.86%
Mar 31, 2023201.9+38.44%
Mar 31, 2022145.9-38.96%
Mar 31, 2021239+745.88%
Mar 31, 202028.3-74.97%
Mar 31, 2019112.9-52.81%
Mar 31, 2018239.2+72.57%
Mar 31, 2017138.6-58.61%
Mar 31, 2016334.9+334.35%
Mar 31, 201577.1-32.56%
Mar 31, 2014114.3-31.22%
Mar 31, 2013166.2+5.69%
Mar 31, 2012157.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)